At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02171 CARSGEN-B
Closed 01-12 16:08:30
16.100
-0.360
-2.19%
High16.540Low15.900Vol1.01M
Open16.460D1 Closing16.460Amplitude3.89%
Mkt Cap9.18BTradable Cap9.18BTotal Shares570.00M
T/O16.36MT/O Rate0.18%Tradable Shares570.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
CARsgen-B (02171) Rises Nearly 6% on Inclusion of Solid Tumor Cell Therapy Project in National Major Scientific Project
Stock News  ·  01-05
CARsgen-B (02171) Rises Nearly 6% on Inclusion of Solid Tumor Cell Therapy Project in National Major Scientific Project
CARSGEN-B (02171) Repurchases 326,000 Shares for HK$4.8477 Million on December 29
Stock News  ·  2025-12-29
CARSGEN-B (02171) Repurchases 326,000 Shares for HK$4.8477 Million on December 29
CARsgen Therapeutics Repurchases 326,000 Shares for HKD 4.85 Million, Files Disclosure with HKEX
Reuters  ·  2025-12-29
CARsgen Therapeutics Repurchases 326,000 Shares for HKD 4.85 Million, Files Disclosure with HKEX
CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Therapy CT0596
Reuters  ·  2025-12-29
CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Therapy CT0596
Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$15.09 Per Share
Stock News  ·  2025-12-24
Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$15.09 Per Share
HK Stock Buyback Summary | Dec 24
Stock News  ·  2025-12-24
HK Stock Buyback Summary | Dec 24
CARSGEN-B (02171) Repurchased 320,000 Shares for HK$4.8609 Million on December 23
Stock News  ·  2025-12-23
CARSGEN-B (02171) Repurchased 320,000 Shares for HK$4.8609 Million on December 23
CARsgen Therapeutics Repurchases 320,000 Shares for HKD 4.86 Million in HKEX Filing
Reuters  ·  2025-12-23
CARsgen Therapeutics Repurchases 320,000 Shares for HKD 4.86 Million in HKEX Filing
Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 18,000 Shares at HK$14.52 per Share
Stock News  ·  2025-12-22
Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 18,000 Shares at HK$14.52 per Share
Is BCMA CAR-T Catalogue Inclusion And Pipeline Progress Altering The Investment Case For CARsgen (SEHK:2171)?
Simply Wall St.  ·  2025-12-20
Is BCMA CAR-T Catalogue Inclusion And Pipeline Progress Altering The Investment Case For CARsgen (SEHK:2171)?
CARsgen Therapeutics Holdings (SEHK:2171): Valuation Check After Zevor‑cel Listing and New CT0596 Data
Simply Wall St.  ·  2025-12-19
CARsgen Therapeutics Holdings (SEHK:2171): Valuation Check After Zevor‑cel Listing and New CT0596 Data
CARsgen Therapeutics Extends Share Repurchase Program
MT Newswires Live  ·  2025-12-19
CARsgen Therapeutics Extends Share Repurchase Program
BRIEF-Carsgen Therapeutics Says Yijie Concert Group Purchased 335,000 Shares From November 6 To December 17
Reuters  ·  2025-12-18
BRIEF-Carsgen Therapeutics Says Yijie Concert Group Purchased 335,000 Shares From November 6 To December 17
CARsgen Therapeutics - Yijie Concert Group Purchased 335,000 Shares From November 6 to December 17
THOMSON REUTERS  ·  2025-12-18
CARsgen Therapeutics - Yijie Concert Group Purchased 335,000 Shares From November 6 to December 17
Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$14.98 per Share
Stock News  ·  2025-12-18
Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$14.98 per Share
HK Stock Buyback Summary | December 18
Stock News  ·  2025-12-18
HK Stock Buyback Summary | December 18
CARSGEN-B Spent HK$6.737 Million to Repurchase 466,000 Shares on December 17
Deep News  ·  2025-12-18
CARSGEN-B Spent HK$6.737 Million to Repurchase 466,000 Shares on December 17
HKEX Share Buyback Summary | December 17
Stock News  ·  2025-12-17
HKEX Share Buyback Summary | December 17
CARsgen Therapeutics Holdings Insider Ups Holding During Year
Simply Wall St.  ·  2025-12-17
CARsgen Therapeutics Holdings Insider Ups Holding During Year
CARSGEN-B (02171) Repurchases 1.01 Million Shares for HK$14.762 Million on December 16
Stock News  ·  2025-12-16
CARSGEN-B (02171) Repurchases 1.01 Million Shares for HK$14.762 Million on December 16

Introduction

Company Name.
CARSGEN-B
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
CARsgen Therapeutics Holdings Ltd is an investment holding company primarily engaged in discovering, researching and developing cell therapies. The Company’s main business is developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The Company mainly operates its businesses in China and overseas markets.
Issue price:
--